CD21 anticorps (C-Term)
Aperçu rapide pour CD21 anticorps (C-Term) (ABIN2240369)
Antigène
Voir toutes CD21 (CR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CR2, CT (Complement Receptor Type 2, Cr2, Complement C3d Receptor, Epstein-Barr Virus Receptor, EBV Receptor, CD21, C3DR)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human CR2 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
-
Autre désignation
- CR2
-
NCBI Accession
- NP_001868
-
UniProt
- P20023
-
Pathways
- Système du Complément
Antigène
-